首站-论文投稿智能助手
典型文献
PRMT5 confers lipid metabolism reprogramming,tumour growth and metastasis depending on the SIRT7-mediated desuccinylation of PRMT5 K387 in tumours
文献摘要:
The protein arginine methyltransferase 5(PRMT5),which is highly expressed in tumour tissues,plays a crucial role in cancer development.However,the mechanism by which PRMT5 promotes cancer growth is poorly understood.Here,we report that PRMT5 contributes to lipid metabolism reprogramming,tumour growth and metastasis depending on the SIRT7-mediated desuccinylation of PRMT5 K387 in tumours.Mass spectrometric analysis identified PRMT5 lysine 387 as its succinylation site.Moreover,the desuccinylation of PRMT5 K387 enhances the methyltransferase activity of PRMT5.SIRT7 catalyses the desuccinylation of PRMT5 in cells.The SIRT7-mediated dessuccinylation of PRMT5 lysine 387 fails to bind to STUB1,decreasing PRMT5 ubiquitination and increasing the interaction between PRMT5 and Mep50,which promotes the formation of the PRMT5-Mep50 octamer.The PRMT5-Mep50 octamer increases PRMT5 methyltransferase activity,leading to arginine methylation of SREBP1a.The symmetric dimethylation of SREBP1a increases the levels of cholesterol,fatty acid,and triglyceride biogenesis in the cells,escaping degradation through the ubiquitin-proteasome pathway.Functionally,the desuccinylation of PRMT5 K387 promotes lipid metabolism reprogramming,tumour growth and metastasis in vitro and in vivo in tumours.
文献关键词:
作者姓名:
Hong-feng Yuan;Man Zhao;Li-na Zhao;Hao-lin Yun;Guang Yang;Yu Geng;Yu-fei Wang;Wei Zheng;Ying Yuan;Tian-qiang Song;Jun-qi Niu;Xiao-dong Zhang
作者机构:
Department of Gastrointestinal Cancer Biology,Tianjin Cancer Institute,Liver Cancer Center,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Tianjin 300060,China;Department of Cancer Research,College of Life Sciences,Nankai University,Tianjin 300071,China;Department of Hepatobiliary Cancer,Liver Cancer Research Center,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China;Department of Hepatology,the First Hospital,Jilin University,Jilin 130021,China
引用格式:
[1]Hong-feng Yuan;Man Zhao;Li-na Zhao;Hao-lin Yun;Guang Yang;Yu Geng;Yu-fei Wang;Wei Zheng;Ying Yuan;Tian-qiang Song;Jun-qi Niu;Xiao-dong Zhang-.PRMT5 confers lipid metabolism reprogramming,tumour growth and metastasis depending on the SIRT7-mediated desuccinylation of PRMT5 K387 in tumours)[J].中国药理学报(英文版),2022(09):2373-2385
A类:
desuccinylation,K387,catalyses,dessuccinylation,Mep50,SREBP1a,dimethylation
B类:
PRMT5,confers,lipid,metabolism,reprogramming,growth,metastasis,depending,SIRT7,mediated,tumours,protein,arginine,methyltransferase,which,highly,expressed,tissues,plays,crucial,role,cancer,development,However,mechanism,by,promotes,poorly,understood,Here,report,that,contributes,Mass,spectrometric,analysis,identified,lysine,its,site,Moreover,enhances,activity,cells,fails,bind,STUB1,decreasing,ubiquitination,increasing,interaction,between,formation,octamer,increases,leading,symmetric,levels,cholesterol,fatty,acid,triglyceride,biogenesis,escaping,degradation,through,proteasome,pathway,Functionally,vitro,vivo
AB值:
0.361498
相似文献
N6?methyladenosine modification of CENPK mRNA by ZC3H13 promotes cervical cancer stemness and chemoresistance
Xian Lin;Feng Wang;Jian Chen;Jing Liu;Yi?Bin Lin;Li Li;Chuan?Ben Chen;Qin Xu-Departments of Gynecology,Fujian Cancer Hospital and Fujian Medical University Cancer Hospital,Fujian Medical University,Fuzhou 350014,China;Department of Radiation Oncology,Fujian Cancer Hospital and Fujian Medical University Cancer Hospital,Fujian Medical University,Fuzhou 350014,China;Shenzhen Key Laboratory of Immunity and Inflammatory Diseases,Peking University Shenzhen Hospital,Shenzhen Peking University?the Hong Kong University of Science and Technology Medical Center,Shenzhen 518036,Guangdong,China;Outpatient Department,Fujian Hospital of People's Armed Police,Fujian Medical University,Fuzhou 350014,China
A causal variant rs3769823 in 2q33.1 involved in apoptosis pathway leading to a decreased risk of non-small cell lung cancer
Xu Zhang;Na Qin;Jingyi Fan;Chang Zhang;Qi Sun;Yayun Gu;Meng Zhu;Erbao Zhang;Juncheng Dai;Guangfu Jin;Hongxia Ma;Zhibin Hu;Hongbing Shen-Department of Epidemiology,Center for Global Health,School of Public Health,Nanjing Medical University,Nanjing 211166,China;Jiangsu Key Lab of Cancer Biomarkers,Prevention and Treatment,Collaborative Innovation Center for Cancer Personalized Medicine,Nanjing Medical University,Nanjing 211166,China;Health Management Center,The Affiliated Suzhou Hospital of Nanjing Medical University,Suzhou Municipal Hospital,Gusu School,Nanjing Medical University,Suzhou 215008,China;Research Units of Cohort Study on Cardiovascular Diseases and Cancers,Chinese Academy of Medical Sciences,Beijing 100730,China
Paired box 5 increases the chemosensitivity of esophageal squamous cell cancer cells by promoting p53 signaling activity
Zhang Weiwei;Yan Wenji;Qian Niansong;Han Quanli;Zhang Weitao;Dai Guanghai-Chinese People’s Liberation Army Medical School, Beijing 100853, China;Department of the Third Health Care, The Second Medical Center, Chinese People’s Liberation Army General Hospital, Beijing 100853, China;Department of Oncology, The First Medical Center, Chinese People’s Liberation Army General Hospital, Beijing 100853, China;Department of Oncology, The Hainan Medical Center, Chinese People’s Liberation Army General Hospital, Sanya 572022, China;Cancer Center, Beijing Tongren Hospital Affiliated to Capital Medical University, Economic and Technological Development Zone, Beijing 100176, China
Deubiquitinase ubiquitin-specific protease 3 (USP3) inhibits HIV-1 replication via promoting APOBEC3G (A3G) expression in both enzyme activity-dependent and -independent manners
Zhao Simin;Zheng Baisong;Wang Liuli;Cui Wenzhe;Jiang Chunlai;Li Zhuo;Gao Wenying;Zhang Wenyan-Center for Pathogen Biology and Infectious Diseases, Institute of Virology and AIDS Research, Key Laboratory of Organ Regeneration and Transplantation of The Ministry of Education, The First Hospital of Jilin University, Changchun, Jilin 130021, China;College of Life Science of Jilin University, Changchun, Jilin 130012, China;Department of Regenerative Medicine, School of Pharmaceutical Sciences, Jilin University, Changchun, Jilin 130012, China;Jilin Provincial Key Laboratory on Molecular and Chemical Genetics, The Second Hospital of Jilin University, Changchun, Jilin 130041, China;Department of Endocrinology and Metabolism, The First Hospital of Jilin University, Changchun, Jilin 130021, China
Nuclear UHRF1 is a gate-keeper of cellular AMPK activity and function
Xiang Xu;Guangjin Ding;Caizhi Liu;Yuhan Ding;Xiaoxin Chen;Xiaoli Huang;Chen-Song Zhang;Shanxin Lu;Yunpeng Zhang;Yuanyong Huang;Zhaosu Chen;Wei Wei;Lujian Liao;Shu-Hai Lin;Jingya Li;Wei Liu;Jiwen Li;Sheng-Cai Lin;Xinran Ma;Jiemin Wong-Shanghai Key Laboratory of Regulatory Biology,Institute of Biomedical Sciences and School of Life Sciences,East China Normal University,Shanghai,China;Zhongshan-Xuhui Hospital,Fudan University and Shanghai Key Laboratory of Medical Epigenetics,the International Co-laboratory of Medical Epigenetics and Metabolism,Ministry of Science and Technology,Institutes of Biomedical Sciences,Fudan University,Shanghai,China;Department of Biochemistry and Department of Cardiology of the Second Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou,Zhejiang,China;State Key Laboratory of Cellular Stress Biology,Innovation Center for Cell Signaling Network,School of Life Sciences,Xiamen University,4221 South Xiang'an Road,Xiamen,Fujian,China;State Key Laboratory of Drug Research,Shanghai Institute of Materia Medica,University of Chinese Academy of Sciences,Chinese Academy of Sciences,Shanghai,China;Department of Biochemistry and Molecular Biology,Program in Molecular and Cell Biology,Zhejiang University School of Medicine,Hangzhou,Zhejiang,China;Joint Center for Translational Medicine,Fengxian District Central Hospital,6600 Nanfeng Road,Shanghai,China
Histone deacetylase inhibitors inhibit cervical cancer growth through Parkin acetylation-mediated mitophagy
Xin Sun;Yuhan Shu;Guiqin Ye;Caixia Wu;Mengting Xu;Ruilan Gao;Dongsheng Huang;Jianbin Zhang-Department of Oncology,Cancer Center of Zhejiang Provincial People's Hospital,Affiliated People's Hospital,Hangzhou Medical College,Hangzhou 310014,China;College of Biomedical Engineering&Instrument Science,Zhejiang University,Hangzhou 310028,China;Key Laboratory of Tumor Molecular Diagnosis and Individualized Medicine of Zhejiang Province,Hangzhou Medical College,Hangzhou 310014,China;Clinical Research Institute,Zhejiang Provincial People,s Hospital,Affiliated People,s Hospital,Hangzhou Medical College,Hangzhou 310014,China;Department of Hematology,the First Affiliated Hospital of Zhejiang Chinese Medical University,Hangzhou 310006,China
Novel dual inhibitor for targeting PIM1 and FGFR1 kinases inhibits colorectal cancer growth in vitro and patient-derived xenografts in vivo
Fanxiang Yin;Ran Zhao;Dhilli Rao Gorja;Xiaorong Fu;Ning Lu;Hai Huang;Beibei Xu;Hanyong Chen;Jung-Hyun Shim;Kangdong Liu;Zhi Li;Kyle Vaughn Laster;Zigang Dong;Mee-Hyun Lee-Department of Pathophysiology,School of Basic Medical Sciences,Zhengzhou University,Zhengzhou 450001,China;China-US(Henan)Hormel Cancer Institute,Zhengzhou 450008,China;Translational Medical Center,the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China;The Hormel Institute,University of Minnesota,Austin,MN 55912,USA;Department of Biomedicine,Health&Life Convergencen Science,BK21 Four,College of Pharmacy,Mokpo National University,Jeonnam 58554,Republic of Korea;The Collaborative Innovation Center of Henan Province for Cancer Chemoprevention,Zhengzhou 450001,China;Department of General Surgery,the Affiliated Tumor Hospital of Zhengzhou University,Zhengzhou 450008,China;College of Korean Medicine,Dongshin University,Naju 58245,Republic of Korea
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。